Please login to the form below

Not currently logged in
Email:
Password:

GSK’s finance SVP joins Parexel International

Simon Harford becomes chief financial officer

Pharmaceutical services provider Parexel International has appointed Simon Harford as chief financial officer and senior vice president from 1 June.

Harford joins from GlaxoSmithKline, where he most recently served as senior vice president of finance, based at the pharma firm's global headquarters in the UK.

Prior to joining GSK in 2009, Harford served as group vice president and controller at cosmetics firm Avon, having previously spent two decades at Eli Lilly in a number of roles including chief financial officer for its EMEA operations.

Josef von Rickenbach, chairman and chief executive of Parexel, said: “Simon brings to Parexel more than three decades of global financial management and investor relations experience in the pharmaceutical industry.

“Simon's leadership will strengthen our ability to accelerate growth and improve profitability as we implement our corporate strategy.”

7th March 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
nzyme

The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....